Viyash Scientific announces partnership with Boehringer Ingelheim to expand companion animal…
Alivira Animal Health Limited (a wholly owned subsidiary of Viyash Scientific Limited) has entered into a partnership agreement…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Boehringer Ingelheim
Big Pharma prepare for next patent cliff as blockbuster drugs revenue losses loom: GlobalData
According to GlobalData’s latest report, there is set to be a smaller proportion of global drug sales which will have patent…
Boehringer Ingelheim launches single-dose poultry vaccine in India covering three major diseases
The new hatchery-administered vaccine provides combined protection against Bursal, Newcastle, and Marek’s disease for broilers,…
Top 20 employers in global biotech and pharma sectors revealed
2024 top biotech and pharma employers survey by Science magazine identifies leading companies in the industry
SIIC IIT Kanpur, Boehringer Ingelheim collaborate to support dementia care innovation
Boehringer Ingelheim’s grant supports Manastik Technologies, an SIIC-incubated startup at IIT Kanpur, in developing India's first…
Prioritised investments from pharma companies shaping competitive pipeline landscape of…
In recent years, bronchiectasis has garnered a significant amount of attention, with pharmaceutical companies prioritising their…
Asthma inhaler price cap in US may help pharma companies to secure more loyal customer base:…
Pharmaceutical manufacturers like Boehringer Ingelheim, GSK, and AstraZeneca are participating in this initiative
Boehringer Ingelheim launches NexGard (afoxolaner) Small and Medium in India
NexGard is indicated for use in dogs and puppies from eight weeks of age and is delivered as a monthly treatment in highly…
Boehringer’s Cyltezo illustrates intersection of price and regulation in biosimilar market: …
Of all the adalimumab biosimilars, Cyltezo is of note due to the company taking the extra and uncommon step of showing…
Boehringer Ingelheim appoints Gagandeep Singh as MD and Head of Human Pharma for India
He joins Boehringer Ingelheim from AstraZeneca, where he was the Managing Director for India and Africa Cluster Head